The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression
Open accessAbstract
NKG2D is an activating receptor for NK, NKT, CD8+, and γδ+ T cells, whose aberrant loss in cancer is a key mechanism of immune evasion. Soluble NKG2D ligands and growth factors, such as TGFβ1 emanating from tumors, are mechanisms for down-regulating NKG2D expression. Cancers thereby impair the capacity of lymphocytes to recognize and destroy them. In this study, we show that exosomes derived from cancer cells express ligands for NKG2D and express TGFβ1, and we investigate the impact of such exosomes on CD8+ T and NK cell NKG2D expression and on NKG2D-dependent functions. Exosomes produced by various cancer cell lines in vitro, or isolated from pleural effusions of mesothelioma patients triggered down-regulation of surface NKG2D expression by NK cells and CD8+ T cells. This decrease was rapid, sustained, and resulted from direct interactions between exosomes and NK cells or CD8+ T cells. Other markers (CD4, CD8, CD56, CD16, CD94, or CD69) remained unchanged, indicating the selectivity and nonactivatory nature of the response. Exosomal NKG2D ligands were partially responsible for this effect, as down-modulation of NKG2D was slightly attenuated in the presence of MICA-specific Ab. In contrast, TGFβ1-neutralizing Ab strongly abrogated NKG2D down-modulation, suggesting exosomally expressed TGFβ as the principal mechanism. Lymphocyte effector function was impaired by pretreatment with tumor exosomes, as these cells exhibited poor NKG2D-dependent production of IFN-γ and poor NKG2D-dependent killing function. This hyporesponsiveness was evident even in the presence of IL-15, a strong inducer of NKG2D. Our data show that NKG2D is a likely physiological target for exosome-mediated immune evasion in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
B lymphocytes secrete antigen-presenting vesicles.
Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., & Geuze, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1161 · Cited by 3,546
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., & Amigorena, S. (1998) · Nature Medicine · doi:10.1038/nm0598-594 · Cited by 2,266
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Théry, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., et al. (2001) · Nature Medicine · doi:10.1038/85438 · Cited by 1,640
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H. (2005) · Nature · doi:10.1038/nature03884 · Cited by 1,308
Malignant effusions and immunogenic tumour-derived exosomes
Andre, F., Schartz, N. E., Movassagh, M., Flament, C., Pautier, P., Morice, P., Pomel, C., Lhomme, C., Escudier, B., Le Chevalier, T., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09552-1 · Cited by 953
Bryceson, Y. T., March, M. E., Ljunggren, H.-G., & Long, E. O. (2006) · Blood · doi:10.1182/blood-2005-04-1351 · Cited by 863
Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles
Andreola, G., Rivoltini, L., Castelli, C., Huber, V., Perego, P., Deho, P., Squarcina, P., Accornero, P., Lozupone, F., Lugini, L., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011624 · Cited by 774
Production and characterization of clinical grade exosomes derived from dendritic cells
Lamparski, H. G., Metha-Damani, A., Yao, J.-Y., Patel, S., Hsu, D.-H., Ruegg, C., & Le Pecq, J.-B. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00330-7 · Cited by 700
Gastpar, R., Gehrmann, M., Bausero, M. A., Asea, A., Gross, C., Schroeder, J. A., & Multhoff, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3804 · Cited by 695
Lipid raft-associated protein sorting in exosomes
de Gassart, A., Géminard, C., Février, B., Raposo, G., & Vidal, M. (2003) · Blood · doi:10.1182/blood-2003-03-0871 · Cited by 672
ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming
Segura, E., Nicco, C., Lombard, B., Véron, P., Raposo, G., Batteux, F., Amigorena, S., & Théry, C. (2005) · Blood · doi:10.1182/blood-2005-01-0220 · Cited by 613
Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane
Booth, A. M., Fang, Y., Fallon, J. K., Yang, J.-M., Hildreth, J. E. K., & Gould, S. J. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200508014 · Cited by 561
Lee, J.-C., Lee, K.-M., Kim, D.-W., & Heo, D. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7335 · Cited by 549
Human Tumor-Derived Exosomes Selectively Impair Lymphocyte Responses to Interleukin-2
Clayton, A., Mitchell, J. P., Court, J., Mason, M. D., & Tabi, Z. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3456 · Cited by 520
Self-citationMurine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function
Liu, C., Yu, S., Zinn, K., Wang, J., Zhang, L., Jia, Y., Kappes, J. C., Barnes, S., Kimberly, R. P., Grizzle, W. E., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1375 · Cited by 500
André, F., Chaput, N., Schartz, N. E. C., Flament, C., Aubert, N., Bernard, J., Lemonnier, F., Raposo, G., Escudier, B., Hsu, D.-H., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2126 · Cited by 496
Induction of heat shock proteins in B-cell exosomes
Clayton, A., Turkes, A., Navabi, H., Mason, M. D., & Tabi, Z. (2005) · Journal of Cell Science · doi:10.1242/jcs.02494 · Cited by 454
Self-citationProteomic Analysis of Exosomes Isolated from Human Malignant Pleural Effusions
Bard, M. P., Hegmans, J. P., Hemmes, A., Luider, T. M., Willemsen, R., Severijnen, L.-A. A., van Meerbeeck, J. P., Burgers, S. A., Hoogsteden, H. C., & Lambrecht, B. N. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0238oc · Cited by 416
Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects
Taylor, D. D., & Gerçel-Taylor, C. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602316 · Cited by 391
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells
Verneris, M. R., Karami, M., Baker, J., Jayaswal, A., & Negrin, R. S. (2004) · Blood · doi:10.1182/blood-2003-06-2125 · Cited by 383
Clayton, A., Harris, C. L., Court, J., Mason, M. D., & Morgan, B. P. (2003) · European Journal of Immunology · doi:10.1002/immu.200310028 · Cited by 345
Self-citationNKG2D function protects the host from tumor initiation
Smyth, M. J., Swann, J., Cretney, E., Zerafa, N., Yokoyama, W. M., & Hayakawa, Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050994 · Cited by 342
Adhesion and signaling by B cell‐derived exosomes: the role of integrins
Clayton, A., Turkes, A., Dewitt, S., Steadman, R., Mason, M. D., & Hallett, M. B. (2004) · The FASEB Journal · doi:10.1096/fj.03-1094fje · Cited by 339
Self-citationPende, D., Cantoni, C., Rivera, P., Vitale, M., Castriconi, R., Marcenaro, S., Nanni, M., Biassoni, R., Bottino, C., Moretta, A., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1076::aid-immu1076>3.0.co;2-y · Cited by 334
Wu, J. D., Higgins, L. M., Steinle, A., Cosman, D., Haugk, K., & Plymate, S. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422206 · Cited by 330
Johnstone, R. M., Mathew, A., Mason, A. B., & Teng, K. (1991) · Journal of Cellular Physiology · doi:10.1002/jcp.1041470105 · Cited by 300
Chaput, N., Schartz, N. E. C., André, F., Taïeb, J., Novault, S., Bonnaventure, P., Aubert, N., Bernard, J., Lemonnier, F., Merad, M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2137 · Cited by 266
Proteolytic Release of Soluble UL16-Binding Protein 2 from Tumor Cells
Waldhauer, I., & Steinle, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2520 · Cited by 245
Systemic NKG2D Down-Regulation Impairs NK and CD8 T Cell Responses In Vivo
Wiemann, K., Mittrücker, H.-W., Feger, U., Welte, S. A., Yokoyama, W. M., Spies, T., Rammensee, H.-G., & Steinle, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.720 · Cited by 240
Vγ9Vδ2 T Cell Response to Colon Carcinoma Cells
Corvaisier, M., Moreau-Aubry, A., Diez, E., Bennouna, J., Mosnier, J.-F., Scotet, E., Bonneville, M., & Jotereau, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5481 · Cited by 207
Direct Immunosuppressive Effects of EBV-Encoded Latent Membrane Protein 1
Dukers, D. F., Meij, P., Vervoort, M. B. H. J., Vos, W., Scheper, R. J., Meijer, C. J. L. M., Bloemena, E., & Middeldorp, J. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.663 · Cited by 206
Dai, S., Wan, T., Wang, B., Zhou, X., Xiu, F., Chen, T., Wu, Y., & Cao, X. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0810 · Cited by 199
Hwang, I., Shen, X., & Sprent, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131852100 · Cited by 188
Silencing Human NKG2D, DAP10, and DAP12 Reduces Cytotoxicity of Activated CD8+ T Cells and NK Cells
Karimi, M. A., Cao, T. M., Baker, J. B., Verneris, M. R., Soares, L. R. B., & Negrin, R. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.7819 · Cited by 133
ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15
Sutherland, C. L., Rabinovich, B. A., Chalupny, N. J., Brawand, P., Miller, R. E., & Cosman, D. J. (2006) · Blood · doi:10.1182/blood-2005-11-011320 · Cited by 109
Recovery of CD8+ T-Cell Function During Systemic Chemotherapy in Advanced Ovarian Cancer
Coleman, S. L., Clayton, A., Mason, M. D., Jasani, B., Adams, M., & Tabi, Z. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3792 · Cited by 90
Self-citationCeccarelli, S., Visco, V., Raffa, S., Wakisaka, N., Pagano, J. S., & Torrisi, M. R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22844 · Cited by 83
Ostler, T., & Ehl, S. R. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00191-6 · Cited by 68
Westwood, J. A., Kelly, J. M., Tanner, J. E., Kershaw, M. H., Smyth, M. J., & Hayakawa, Y. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.757 · Cited by 49
NKG2D-independent suppression of T cell proliferation by H60 and MICA
Kriegeskorte, A. K., Gebhardt, F. E., Porcellini, S., Schiemann, M., Stemberger, C., Franz, T. J., Huster, K. M., Carayannopoulos, L. N., Yokoyama, W. M., Colonna, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502026102 · Cited by 39
Cited by
Biological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926
Membrane vesicles as conveyors of immune responses
Théry, C., Ostrowski, M., & Segura, E. (2009) · Nature Reviews Immunology · doi:10.1038/nri2567 · Cited by 3,882
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
The biology and function of exosomes in cancer
Kalluri, R. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81135 · Cited by 1,849
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
Metadata
- Authors
- Clayton, A., Mitchell, J. P., Court, J., Linnane, S., Mason, M. D., & Tabi, Z.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-06-01
- Volume
- 180
- Issue
- 11
- Pages
- 7249-7258
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1894510512
- Cited by
- 574
- References
- 42
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.